Richard Pulik
Director of Finance/CFO bij ROIVANT SCIENCES LTD.
Vermogen: 3 M $ op 29-02-2024
Profiel
Momenteel bekleedt Richard Pulik de functie van Chief Financial Officer voor Roivant Sciences Ltd. en Chief Financial Officer voor Roivant Sciences, Inc. (een dochteronderneming van Roivant Sciences Ltd.). In het verleden was de heer Pulik Global Head-Business Development & Licensing bij Novartis Pharmaceuticals Corp. Hij behaalde een bachelordiploma aan de Universiteit van Pennsylvania en een bachelordiploma aan The Wharton School van de Universiteit van Pennsylvania.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
ROIVANT SCIENCES LTD.
0.03% | 28-02-2024 | 269 553 ( 0.03% ) | 3 M $ | 29-02-2024 |
Actieve functies van Richard Pulik
Bedrijven | Functie | Begin |
---|---|---|
ROIVANT SCIENCES LTD. | Director of Finance/CFO | 28-09-2021 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Director of Finance/CFO | 28-09-2021 |
Eerdere bekende functies van Richard Pulik
Bedrijven | Functie | Einde |
---|---|---|
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01-08-2021 |
Opleiding van Richard Pulik
University of Pennsylvania | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ROIVANT SCIENCES LTD. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Health Technology |